Trypsin Market To Reach $131.5 Billion By 2030 | CAGR: 5.4%

Trypsin Market Growth & Trends

The global trypsin market size is estimated to reach USD 131.5 billion by 2030, registering a CAGR of 5.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing adoption of trypsin across various industries, such as pharmaceuticals, food science research, detergents, and leather-bating, is likely to drive the market growth. Where as various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis, along with increasing focus on drug discovery and development is expected to further propel the market growth.

Trypsin is widely being used in R&D in pharmaceutical, food, and environmental industries, owing to its special digestive functions of hydrolyzing proteins. It acts as a raw material for internal medicine in endocrine diseases and clinical surgery. The use of enzyme catalysts has been scaled up for commercial processes in the pharmaceutical, beverages, and food industries. These enzymes help in waste reduction, which makes them highly efficient to be used in food, pharmaceuticals, and feed industries. Moreover, the best source of trypsin, TRYPSIN VI, has found nutraceutical use as an anti-inflammatory treatment and a digestive supplement for veterinary & human applications.

Various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis. Increase in R&D expenditure, the rising drug launches, and FDA approvals.

 Request a free sample copy or view report summary: Trypsin Market Report

Trypsin Market Report Highlights

• Based on source, the bovine segment led the market with the largest revenue share of 59.71% in 2024, owing to prominent application in field of clinical diagnostics, research, food and beverage industry and meat tenderization

• Based on source, the porcine segment is expected to grow at the significant CAGR over the forecast period

• Based on application, the biotechnology and pharmaceutical industry segment held the market with the largest revenue share of 56.40% in 2024, and is further anticipated to witness the fastest CAGR over the forecast period. The increasing focus on drug discovery and development is further propelling growth

• North America dominated the market with the largest revenue share of 40.49% in 2024, owing to factors such as increasing the prevalence of various cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

• In Dec 2023, Creative Enzymes, a global pioneer in professional enzyme related products and services unveiled its combination product offerings for proteolytic enzymes such as Trypsin-Chymotrypsin, with this company aims at optimizing the speed and efficiency of the digestive process opening new possibilities for medical and pharmaceutical enhancements.

Trypsin Market Segmentation

Grand View Research has segmented the global trypsin market on the basis of source, application, end-use, and regions:

Trypsin Source Outlook (Revenue, USD Million, 2018 - 2030)

• Bovine

• Porcine

• Others

Trypsin Application Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology and Pharmaceutical Industry

• Food Industry

• Cosmetics and Personal Care

• Waste Treatment

• Others

Trypsin End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Research

• Diagnostic

• Industrial use

Trypsin Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Trypsin Market

• Merck Millipore

• Novozymes

• Agilent Technologies

• Thermo Fisher Scientific

• Sartorius AG

• Neova Technologies

• BIOZYM

• PromoCell GmbH

• Promega Corporation

• Bovogen Biologicals

• Zymetech

• BBI Solutions

• Linzyme Biosciences